Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

The following is a summary of “Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31.

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

As everyone knows, scratching at chronically itchy skin only makes the problem worse. A new device is claimed to help stop ...